REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 116 filers reported holding REVANCE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 2.86 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $2,306,845 | -41.3% | 468,871 | +36.9% | 0.69% | -43.5% |
| Q3 2023 | $3,928,211 | +9.7% | 342,477 | +142.0% | 1.22% | +33.5% |
| Q2 2023 | $3,581,365 | +151.7% | 141,500 | +61.3% | 0.91% | +168.7% |
| Q4 2019 | $1,423,000 | -64.2% | 87,700 | -71.3% | 0.34% | -73.5% |
| Q3 2019 | $3,974,000 | -24.1% | 305,664 | -24.3% | 1.28% | +1.4% |
| Q2 2019 | $5,236,000 | +30.5% | 403,664 | +58.6% | 1.26% | +16.5% |
| Q1 2019 | $4,012,000 | +18.8% | 254,581 | +51.8% | 1.08% | -12.0% |
| Q4 2018 | $3,376,000 | -17.3% | 167,724 | +2.1% | 1.23% | -12.2% |
| Q3 2018 | $4,084,000 | +46.9% | 164,353 | +62.3% | 1.40% | -8.8% |
| Q2 2018 | $2,780,000 | – | 101,292 | – | 1.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,592,047 | $121,230,000 | 21.92% |
| Rhenman & Partners Asset Management AB | 220,000 | $5,808,000 | 0.83% |
| ArrowMark Colorado Holdings LLC | 2,045,862 | $54,011,000 | 0.67% |
| Vivo Capital, LLC | 77,373 | $2,043,000 | 0.52% |
| Ghost Tree Capital, LLC | 89,295 | $2,357,000 | 0.49% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 124,932 | $3,298,000 | 0.47% |
| Polar Capital LLP | 1,296,371 | $34,220,000 | 0.46% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 70,095 | $1,851,000 | 0.24% |
| EAM Investors, LLC | 33,897 | $895,000 | 0.15% |
| PointState Capital LP | 438,200 | $11,568,000 | 0.13% |